"The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflam"...
(Generic versions may still be available.)
LIVOSTIN™ 0.05% (levocabastine hydrochloride ophthalmic suspension) is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis.
DOSAGE AND ADMINISTRATION
SHAKE WELL BEFORE USING. The usual dose is one drop instilled in affected eyes four times per day.
LIVOSTIN™ 0.05% (levocabastine hydrochloride ophthalmic suspension), 2.5 mL, 5 mL, and 10 mL is provided in white, polyethylene dropper tip squeeze bottles.
Keep tightly closed when not in use.
Do not use if the suspension has discolored.
Store at controlled room temperature 15°to 30°C (59° to 86°F).
Protect from freezing.
NDC 58768-610-10 (10.0 mL)
NDC 58768-610-05 (5.0 mL)
NDC 58768-610-99 (2.5 mL)
Levocabastine hydrochloride is an original product of Janssen Pharmaceutica Inc.
Mfd. by OMJ Pharmaceuticals, Inc., San Germán, P.R., 00683 for: Novartis Ophthalmics, Duluth, GA 30097
Last reviewed on RxList: 6/11/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Livostin Information
Livostin - User Reviews
Livostin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.